These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26457878)

  • 1. Tumor-binding antibodies and tumor immunity.
    Carmi Y; Engleman EG
    Oncotarget; 2015 Nov; 6(34):35129-30. PubMed ID: 26457878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z; Herlyn D; Maul G; Koprowski H
    Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for immunotoxin therapy in cancer.
    Frankel AE; Houston LL; Issell BF; Fathman G
    Annu Rev Med; 1986; 37():125-42. PubMed ID: 3518602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hyperthermia on the immunological system with regard to antineoplastic immunity].
    Roszkowski W
    Postepy Hig Med Dosw; 1981; 35(5):451-70. PubMed ID: 6752919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of antibodies in the process of neoplasm development].
    Strzelecka G; Hałasa J; Dabrowski W
    Pol Tyg Lek; 1978 Nov; 33(46):1801-4. PubMed ID: 714791
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of IgG monoclonal antibodies to the tumor-associated antigen, CA-195.
    Kuus-Reichel K; Knott CL; McCormack RT; Guido MS; Beebe A
    Hybridoma; 1994 Feb; 13(1):31-6. PubMed ID: 8200656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of cancer using immuno-antibodies and application of monoclonal tumor antibodies].
    Koji T
    Rinsho Hoshasen; 1982 Sep; 27(9):879-85. PubMed ID: 6759722
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-idiotypic antibodies in tumor immunity].
    Miura K
    Nihon Rinsho; 1988 Dec; 46(12):2778-85. PubMed ID: 3071628
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioimmunoglobulin therapy of cancer.
    Order SE
    Compr Ther; 1984 Jan; 10(1):9-18. PubMed ID: 6692670
    [No Abstract]   [Full Text] [Related]  

  • 15. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines.
    Yip YL; Ward RL
    Cancer Immunol Immunother; 2002 Jan; 50(11):569-87. PubMed ID: 11807621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies in cancer treatment.
    Baldwin RW; Byers VS
    Lancet; 1986 Mar; 1(8481):603-5. PubMed ID: 2869313
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant chimeric monoclonal antibodies.
    Morrison SL; Schlom J
    Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.